Engineering CpG-Free ITR for AAV Gene Therapy

被引：0
|
作者：
Pan, Xiufang [1 ]
Yue, Yongping [1 ]
Wasala, Lakmini [1 ]
Zhang, Keqing [1 ]
Duan, Dongsheng [1 ,2 ,3 ,4 ]
机构：
[1] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA
[2] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO USA
[3] Univ Missouri, Sch Med, Dept Neurol, Columbia, MO USA
[4] Univ Missouri, Coll Engn, Dept Biomed Biol & Chem Engn, Columbia, MO USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
516
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [41] Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy
    Rodriguez-Marquez, Esther
    Meumann, Nadja
    Buening, Hildegard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 749 - 766
  • [42] Semi-rational engineering of next-generation AAV capsids for muscle gene therapy
    El Andari, J.
    Kraemer, C.
    Ayhan, S.
    Dietz, L.
    Grimm, D.
    HUMAN GENE THERAPY, 2019, 30 (11) : A7 - A7
  • [43] Biological activity of additional AAV subpopulation in AAV gene therapy product
    Bort, J. Hernandez
    Kraus, B.
    Fiedler, C.
    Buengener, C.
    Mayrhofer, J.
    Lengler, J.
    Schlager, R.
    Bendik, M.
    HUMAN GENE THERAPY, 2018, 29 (12) : A44 - A44
  • [44] Engineering Novel AAV Capsids for Cardiac Gene Delivery
    Cheng, Ze
    Easter, Emilee
    Feathers, Charles
    Leong, Jackson
    Lim, Beatriz
    Jones, Samantha
    Woods, Joe
    Parvathaneni, Alekhya
    Reid, Christopher A.
    Nettesheim, Emily R.
    Doerner, Karl
    Lin, JianMin
    Jing, Frank
    Tingley, Whittemore
    Hoey, Timothy
    Ivey, Kathryn N.
    Lombardi, Laura M.
    MOLECULAR THERAPY, 2023, 31 (04) : 238 - 238
  • [45] Computationally guided AAV engineering for enhanced gene delivery
    Guo, Jingxuan
    Lin, Li F.
    Oraskovich, Sydney V.
    Jesus, Julio A. Rivera de
    Listgarten, Jennifer
    V. Schaffer, David
    TRENDS IN BIOCHEMICAL SCIENCES, 2024, 49 (05) : 457 - 469
  • [46] Engineering novel AAV capsids for cardiac gene delivery
    Cheng, Z.
    Parvathaneni, A.
    Easter, E.
    Reid, C. A.
    Nettesheim, E. R.
    Zhou, H.
    Xu, E.
    Lin, J.
    Tingley, W.
    Hoey, T.
    Ivey, K. N.
    Lombardi, L. M.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A30 - A31
  • [47] Engineering Novel AAV Capsids for Cardiac Gene Delivery
    Cheng, Ze
    Parvathaneni, Alekhya
    Reid, Christopher A.
    Nettesheim, Emily R.
    Easter, Emilee
    Greer-Short, Amara
    Feathers, Charles
    Chung, Tae Won
    Rodriguez, Neshel
    Lim, Beatriz
    Lin, JianMin
    Tingley, Whittemore
    Hoey, Timothy
    Ivey, Kathryn N.
    Lombardi, Laura
    MOLECULAR THERAPY, 2022, 30 (04) : 294 - 295
  • [48] Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design
    Kosovac, D.
    Wild, J.
    Ludwig, C.
    Meissner, S.
    Bauer, A. P.
    Wagner, R.
    GENE THERAPY, 2011, 18 (02) : 189 - 198
  • [49] Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design
    D Kosovac
    J Wild
    C Ludwig
    S Meissner
    A P Bauer
    R Wagner
    Gene Therapy, 2011, 18 : 189 - 198
  • [50] AAV gene therapy continues to woo investors
    Barbara Cassasus
    Nature Biotechnology, 2014, 32 (4) : 302 - 302
12345